Skip to content

Clinical trials

Autism Spectrum Disorder trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Phase: Not applicable Country / region: China Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20182
20193
20201
20212
20227
202310
20248
20258
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting10
Unknown status8
Not yet recruiting6
Withdrawn1
Enrolling by invitation1
Terminated1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital of Fudan University4
Central South University3
Changping Laboratory3
Peking University3
The University of Hong Kong3
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine3
Harbin Medical University2
Hunan Normal University2
The Second Hospital of Nanjing Medical University2
Arizona State University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder48
Autistic Disorder8
Learning Disabilities3
Attention Deficit Disorder with Hyperactivity1
Cerebral Palsy1
Communication Disorders1
Developmental Disabilities1
Down Syndrome1
Epilepsy1
Intellectual Disability1

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.